Chugai Pharmaceutical Co Ltd (CHGCY)
20.69
+0.21
(+1.03%)
USD |
OTCM |
Nov 21, 16:00
Chugai Pharmaceutical Gross Profit Margin (Quarterly): 73.32% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 73.32% |
| June 30, 2024 | 72.16% |
| March 31, 2024 | 69.21% |
| December 31, 2023 | 66.38% |
| September 30, 2023 | 69.66% |
| June 30, 2023 | 65.72% |
| March 31, 2023 | 51.53% |
| December 31, 2022 | 51.45% |
| September 30, 2022 | 69.33% |
| June 30, 2022 | 66.12% |
| March 31, 2022 | 68.25% |
| December 31, 2021 | 65.69% |
| September 30, 2021 | 63.73% |
| June 30, 2021 | 69.26% |
| March 31, 2021 | 67.22% |
| December 31, 2020 | 65.66% |
| September 30, 2020 | 66.72% |
| June 30, 2020 | 62.60% |
| March 31, 2020 | 65.85% |
| December 31, 2019 | 63.87% |
| September 30, 2019 | 60.75% |
| June 30, 2019 | 61.40% |
| March 31, 2019 | 58.58% |
| December 31, 2018 | 55.76% |
| September 30, 2018 | 53.34% |
| Date | Value |
|---|---|
| June 30, 2018 | 52.62% |
| March 31, 2018 | 56.70% |
| December 31, 2017 | 53.83% |
| September 30, 2017 | 51.76% |
| June 30, 2017 | 52.65% |
| March 31, 2017 | 51.25% |
| December 31, 2016 | 50.81% |
| September 30, 2016 | 48.39% |
| June 30, 2016 | 49.98% |
| March 31, 2016 | 48.97% |
| December 31, 2015 | 53.07% |
| September 30, 2015 | 51.81% |
| June 30, 2015 | 51.67% |
| March 31, 2015 | 50.68% |
| December 31, 2014 | 52.42% |
| September 30, 2014 | 50.89% |
| June 30, 2014 | 51.90% |
| March 31, 2014 | 55.26% |
| December 31, 2013 | 54.08% |
| September 30, 2013 | 57.49% |
| June 30, 2013 | 57.00% |
| March 31, 2013 | 54.89% |
| December 31, 2012 | 57.75% |
| September 30, 2012 | 56.13% |
| June 30, 2012 | 55.72% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
51.45%
Minimum
Dec 2022
73.32%
Maximum
Sep 2024
65.69%
Average
66.25%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 66.47% |
| Nxera Pharma Co Ltd | 78.44% |
| PeptiDream Inc | 47.13% |
| Healios KK | 86.35% |
| AnGes Inc | 31.07% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.98% |
| Return on Assets | 20.10% |
| Return on Invested Capital | 23.65% |
| Profit Margin (Quarterly) | 34.69% |
| Operating Margin (Quarterly) | 50.81% |
| Return on Net Operating Assets | 37.79% |